We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$819M
AUM Growth
+$123M
(+18%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
9.75%
Holding
710
New
168
Increased
162
Reduced
95
Closed
285
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$9.74M |
| 2 |
McDonald's
MCD
|
+$8.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$8.03M |
| 4 |
AGN
Allergan plc
AGN
|
+$7.37M |
| 5 |
Henry Schein
HSIC
|
+$6.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$7.17M |
| 2 |
Lam Research
LRCX
|
+$6.99M |
| 3 |
Electronic Arts
EA
|
+$6.98M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
+$6.79M |
| 5 |
Hilton Worldwide
HLT
|
+$6.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.19% |
| 2 | Technology | 15.05% |
| 3 | Consumer Discretionary | 14.44% |
| 4 | Financials | 11.43% |
| 5 | Consumer Staples | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
RH
RH
$3.36B
| $5.91M | 0.72% |
84,101
+57,073
| +211% | +$3.58M |
|
27
Occidental Petroleum
OXY
$53.6B
| $5.9M | 0.72% |
91,949
+87,800
| +2,116% | +$5.35M |
|
28
Conagra Brands
CAG
$7.38B
| $5.83M | 0.71% |
172,823
+152,100
| +734% | +$5.17M |
|
29
Everest Group
EG
$15.8B
| $5.8M | 0.71% |
+25,400
| New | +$6.4M |
|
30
Marathon Petroleum
MPC
$89.3B
| $5.74M | 0.7% |
102,416
-7,600
| -7% | -$408K |
|
31
Honeywell
HON
$78.3B
| $5.67M | 0.69% |
44,315
+28,560
| +181% | +$3.54M |
|
32
FMC
FMC
$1.37B
| $5.55M | 0.68% |
+71,717
| New | +$5.15M |
|
33
PepsiCo
PEP
$195B
| $5.39M | 0.66% |
+48,400
| New | +$5.59M |
|
34
Autodesk
ADSK
$50.1B
| $5.39M | 0.66% |
48,031
-2,500
| -5% | -$276K |
|
35
Kinder Morgan
KMI
$70.3B
| $5.36M | 0.65% |
279,308
+32,300
| +13% | +$629K |
|
36
Cintas
CTAS
$86B
| $5.34M | 0.65% |
+148,100
| New | +$4.93M |
|
|
ICPT
37
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.25M | 0.64% |
+90,387
| New | +$9.74M |
|
|
KSU
38
DELISTED
Kansas City Southern
KSU
| $5.15M | 0.63% |
47,400
+32,500
| +218% | +$3.41M |
|
39
Oracle
ORCL
$346B
| $5.12M | 0.62% |
105,781
-4,900
| -4% | -$244K |
|
|
LVLT
40
DELISTED
Level 3 Communications Inc
LVLT
| $5.1M | 0.62% |
95,665
+86,600
| +955% | +$4.83M |
|
41
Carnival Corporation Ltd
CCL
$38.7B
| $5.05M | 0.62% |
+78,176
| New | +$5.23M |
|
42
Dollar Tree
DLTR
$24.4B
| $4.94M | 0.6% |
56,897
-34,700
| -38% | -$2.65M |
|
43
General Motors
GM
$81.7B
| $4.91M | 0.6% |
+121,536
| New | +$4.44M |
|
44
Ameriprise Financial
AMP
$48.3B
| $4.81M | 0.59% |
32,400
-700
| -2% | -$97.7K |
|
45
Edwards Lifesciences
EW
$48.2B
| $4.8M | 0.59% |
+131,811
| New | +$5.03M |
|
46
Abbott
ABT
$187B
| $4.76M | 0.58% |
+89,212
| New | +$4.48M |
|
47
Illumina
ILMN
$29.2B
| $4.64M | 0.57% |
+23,952
| New | +$4.46M |
|
48
Tyson Foods
TSN
$21.5B
| $4.52M | 0.55% |
+64,118
| New | +$4.1M |
|
49
Prudential Financial
PRU
$43B
| $4.5M | 0.55% |
42,351
+35,800
| +546% | +$3.83M |
|
50
Micron Technology
MU
$927B
| $4.35M | 0.53% |
+110,611
| New | +$3.5M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Seven Eight Capital held 710 positions worth $819M, up 18% from $696M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $101M of net new capital in Q3 2017, opening 168 new positions and adding to 162 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Constellation Brands, an estimated $6.37M trimmed.
- Seven Eight Capital's largest Q3 2017 buy was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
- Seven Eight Capital added most to McDonald's in Q3 2017, an estimated $8.2M increase.
- Seven Eight Capital's biggest Q3 2017 reduction was Constellation Brands, cutting an estimated $6.37M.
- Seven Eight Capital fully exited Nike in Q3 2017, selling an estimated $7.17M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $819M portfolio in Q3 2017.
- Seven Eight Capital opened 168 new positions and closed 285 in Q3 2017.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $819M.
Based on Seven Eight Capital's 13F filing for Q3 2017, filed 16 Oct 2017.